Substance / Medication

Norfloxacin

Overview

Active Ingredient
norfloxacin
RxNorm CUI
7517

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.
Mücke Marcus M, Mücke Victoria T, Graf Christiana et al. · Clin Transl Gastroenterol · 2020
PMID: 32955202Meta-AnalysisFull text (PMC)
Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
Kulkarni Anand V, Tirumalle Sowmya, Premkumar Madhumita et al. · Am J Gastroenterol · 2022
PMID: 35041634RCT
Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation.
Khiljee Sonia, Ahmad Mahmood, Murtaza Ghulam et al. · Pak J Pharm Sci · 2011
PMID: 21959800RCT
Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial.
Gupta Samir, Faughnan Marie E, Lilly Les et al. · Clin Gastroenterol Hepatol · 2010
PMID: 20816858RCT
Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis.
Zapater Pedro, Caño Rocío, Llanos Lucía et al. · Gastroenterology · 2009
PMID: 19660462RCT
Validation of a reversed-phase high-performance liquid chromatography method with fluorescence detection for the bioequivalence study of norfloxacin in plasma samples.
Maia Maria Bernadete Sousa, Martins Ismael Leite, do Nascimento Demétrius Fernandes et al. · Ther Drug Monit · 2008
PMID: 18520606RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Norfloxacin (substance)
SNOMED CT
387271008
UMLS CUI
C0028365
RxNorm CUI
7517

Clinical Data

This intervention maps to 19 entities in the Healos knowledge graph.

14
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Norfloxacin — Conditions, Biomarkers & Specialists | Healos | Healos